TY - JOUR
T1 - Jansen-de Vries syndrome
T2 - Expansion of the PPM1D clinical and phenotypic spectrum in 34 families
AU - Wojcik, Monica H.
AU - Srivastava, Siddharth
AU - Agrawal, Pankaj B.
AU - Balci, Tugce B.
AU - Callewaert, Bert
AU - Calvo, Pier Luigi
AU - Carli, Diana
AU - Caudle, Michelle
AU - Colaiacovo, Samantha
AU - Cross, Laura
AU - Demetriou, Kalliope
AU - Drazba, Katy
AU - Dutra-Clarke, Marina
AU - Edwards, Matthew
AU - Genetti, Casie A.
AU - Grange, Dorothy K.
AU - Hickey, Scott E.
AU - Isidor, Bertrand
AU - Küry, Sébastien
AU - Lachman, Herbert M.
AU - Lavillaureix, Alinoe
AU - Lyons, Michael J.
AU - Marcelis, Carlo
AU - Marco, Elysa J.
AU - Martinez-Agosto, Julian A.
AU - Nowak, Catherine
AU - Pizzol, Antonio
AU - Planes, Marc
AU - Prijoles, Eloise J.
AU - Riberi, Evelise
AU - Rush, Eric T.
AU - Russell, Bianca E.
AU - Sachdev, Rani
AU - Schmalz, Betsy
AU - Shears, Deborah
AU - Stevenson, David A.
AU - Wilson, Kate
AU - Jansen, Sandra
AU - de Vries, Bert B.A.
AU - Curry, Cynthia J.
N1 - Funding Information:
Herbert M. Lachman is supported by the NIH/NIMH (R21 MH131740) and the NIH/NICHD (P30 HD071593) to the Albert Einstein College of Medicine's Rose F. Kennedy Intellectual and Developmental Disabilities Research Center. Monica H. Wojcik is supported by NIH/NICHD (K23 HD102589). Siddharth Srivastava is supported by NIH/NINDS (K23 NS119666). The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health. Bert B. A. de vries is supported by the Dutch Organization for Health Research and Development: ZON‐MW grant (912‐12‐109). Bert Callewaert is a senior clinical investigator of the Research Foundation‐Flanders.
Publisher Copyright:
© 2023 Wiley Periodicals LLC.
PY - 2023/7
Y1 - 2023/7
N2 - Jansen-de Vries syndrome (JdVS) is a neurodevelopmental condition attributed to pathogenic variants in Exons 5 and 6 of PPM1D. As the full phenotypic spectrum and natural history remain to be defined, we describe a large cohort of children and adults with JdVS. This is a retrospective cohort study of 37 individuals from 34 families with disease-causing variants in PPM1D leading to JdVS. Clinical data were provided by treating physicians and/or families. Of the 37 individuals, 27 were male and 10 female, with median age 8.75 years (range 8 months to 62 years). Four families document autosomal dominant transmission, and 32/34 probands were diagnosed via exome sequencing. The facial gestalt, including a broad forehead and broad mouth with a thin and tented upper lip, was most recognizable between 18 and 48 months of age. Common manifestations included global developmental delay (35/36, 97%), hypotonia (25/34, 74%), short stature (14/33, 42%), constipation (22/31, 71%), and cyclic vomiting (6/35, 17%). Distinctive personality traits include a hypersocial affect (21/31, 68%) and moderate-to-severe anxiety (18/28, 64%). In conclusion, JdVS is a clinically recognizable neurodevelopmental syndrome with a characteristic personality and distinctive facial features. The association of pathogenic variants in PPM1D with cyclic vomiting bears not only medical attention but also further pathogenic and mechanistic evaluation.
AB - Jansen-de Vries syndrome (JdVS) is a neurodevelopmental condition attributed to pathogenic variants in Exons 5 and 6 of PPM1D. As the full phenotypic spectrum and natural history remain to be defined, we describe a large cohort of children and adults with JdVS. This is a retrospective cohort study of 37 individuals from 34 families with disease-causing variants in PPM1D leading to JdVS. Clinical data were provided by treating physicians and/or families. Of the 37 individuals, 27 were male and 10 female, with median age 8.75 years (range 8 months to 62 years). Four families document autosomal dominant transmission, and 32/34 probands were diagnosed via exome sequencing. The facial gestalt, including a broad forehead and broad mouth with a thin and tented upper lip, was most recognizable between 18 and 48 months of age. Common manifestations included global developmental delay (35/36, 97%), hypotonia (25/34, 74%), short stature (14/33, 42%), constipation (22/31, 71%), and cyclic vomiting (6/35, 17%). Distinctive personality traits include a hypersocial affect (21/31, 68%) and moderate-to-severe anxiety (18/28, 64%). In conclusion, JdVS is a clinically recognizable neurodevelopmental syndrome with a characteristic personality and distinctive facial features. The association of pathogenic variants in PPM1D with cyclic vomiting bears not only medical attention but also further pathogenic and mechanistic evaluation.
KW - Jansen-de Vries syndrome
KW - PPM1D
KW - cyclic vomiting
KW - developmental delay
KW - hypersocial personality
UR - http://www.scopus.com/inward/record.url?scp=85159181090&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.63226
DO - 10.1002/ajmg.a.63226
M3 - Article
C2 - 37183572
AN - SCOPUS:85159181090
SN - 1552-4825
VL - 191
SP - 1900
EP - 1910
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 7
ER -